Portfolio company
Albio (PAL Finland)
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops portable point-of-care blood alcohol testing devices for paramedics and emergency departments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Orphan diagnostics
This company develops point-of-care bedside tests to detect methanol poisoning for healthcare providers and emergency medical services.
Abionic
This company develops nanofluidic point-of-care diagnostic platforms and blood tests for healthcare professionals to enable rapid detection of sepsis, allergies and iron deficiencies.
Upfront Diagnostics
The company develops rapid point-of-care blood tests for stroke identification, serving paramedics, emergency medical services, and hospital clinicians.
The ThermoTraumaPort (TTP)
This company develops a heated emergency patient transfer device for paramedics and hospital staff to manage trauma and critically ill patients.
StrokeDx
This company develops portable, non-invasive neuroimaging devices and software for rapid bedside stroke detection and monitoring for healthcare providers and emergency services.
AI Stroke
This company develops a mobile application using artificial intelligence and video analysis to assist paramedics and emergency departments in detecting strokes.
410 Medical
This company develops handheld rapid infusion devices to deliver fluids and blood to critically ill patients for hospitals and emergency medical services.
Alveo
This company develops portable molecular diagnostic platforms for rapid pathogen detection in agriculture, food safety, environmental monitoring, and human healthcare sectors.
